Differential requirement for NF-κB-inducing kinase in the induction of NF-κB by IL-1β, TNF-α, and Fas

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Russo, Maria P ^a   Bennett, Brydon L ^a   Manning, Anthony M ^b   Brenner, David A ^a   Jobin, Christian ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CELGENE CORPORATION   (United States)

^c IL   (United States)

Author keywords

Inflammation; Interleukin 8; Intestinal epithelial cells; Signal transduction

Indexed keywords

CYTOKINE; DNA; FAS ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PHOSPHOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036088931     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00166.2001     Document Type: Article

References (65)

1. Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells
2. Fas activates the JNK pathway in human colonic epithelial cells: Lack of a direct role in apoptosis
3. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen
4. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells
5. Modulation of life and death by the TNF receptor superfamily
6. Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases
7. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor
8. Fas/Apo (apoptosis)-1 and associated proteins in the differentiating cerebral cortex: Induction of caspase-dependent cell death and activation of NF-κB
9. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases
10. IKAP is a scaffold protein of the IκB kinase complex
11. Fas and other cell death signaling pathways
12. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF-2 recruits IKK to TNF-R1 while RIP mediates IKK activation
13. Lineage-restricted function of nuclear factor-κB-inducing kinase (NIK) in transducing signals via CD 40
14. NSAID butyrate sensitize a human colorectal cancer cell line to TNF-α and Fas ligation: The role of reactive oxygen species
15. Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by fas ligation
16. Construction of adenovirus vectors through Cre-lox recombination
17. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines
18. Evidence for an altered regulation of IκBα degradation in human colonic epithelial cells
19. TRAF-2 is involved in both IL-1β- and TNF-αsignaling cascade leading to NF-κB activation and IL-8 expression in human intestinal epithelial cells
20. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of an NF-κB super-repressor in human intestinal epithelial cells
21. The IκB/NF-κB system: A key determinant of mucosal inflammation and protection
22. NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases
23. The beginning of the end: IκB kinase (IKK) and NF-κB activation
24. JNK or IKK AP-1 or NF-κB, which are the targets for MEK kinase 1 action?
25. Activation of IκB kinase β by protein kinase C isoforms
26. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway
27. MEKK1 activates both IκB kinase α and IκB kinase β
28. Molecular determinants of NF-κB-inducing kinase action
29. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176
30. Lymphotoxin-β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types
31. Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
32. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
33. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-α-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis
34. Essential role of nuclear factor (NF)-κB-inducing kinase and inhibitor of κB (IκB) kinase α in NF-κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I
35. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
36. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
37. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice
38. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
39. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2
40. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase
41. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signaling
42. Signal transduction pathways activated by IL-1 receptor family: Ancient machinery in mammals, insects, and plants
43. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
44. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
45. The CD95 (APO/Fas) receptor activates NF-κB independently of its cytotoxic function
46. Identification and characterization of an IκB kinase
47. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
48. IKK-γg is an essential regulatory subunit of the IκB kinase complex
49. IκB kinase β (IKKβ), but not NF-κB-inducing kinase (NIK) or IKKα, represents a therapeutic target for modulation of Fas, IL-1β and TNFα-mediated NF-κB activation in intestinal epithelial cells
50. Increased susceptibility to Fas-mediated apoptosis in differentiated HT-29 cells independent of its effects on NF-κB activation and IL-8 secretion
51. Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation
52. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation
53. NEMO/IKKγ-deficient mice model incontinentia pigmenti
54. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase
55. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit
56. NF-κB a key role in inflammatory diseases
57. Tumor necrosis factor receptor and Fas signaling mechanisms
58. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
59. Regulatory role of phosphatidylinositol 3-kinase on TNF-α-induced cyclooxygenase 2 expression in colonic epithelial cells
60. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK
61. Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice
62. 2-terminal kinase regulation but does not cause a measurable defect in NF-κB activation
63. Bridging the gap: Composition, regulation, and physiological function of the IκB kinase complex
64. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
65. Mitogen-activated protein kinase/ERK kinase kinase 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β